Evaluation of infection with human immunodeficiency virus type 1 by using nonisotopic solution hybridization for detection of polymerase chain reaction-amplified proviral DNA. NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Evaluation of infection with human immunodeficiency virus type 1 by using nonisotopic solution hybridization for detection of polymerase chain reaction-amplified proviral DNA.

J Clin Microbiol. 1991 Nov;29(11):2461-7. Unique Identifier : AIDSLINE MED/92129512
Coutlee F; Saint-Antoine P; Olivier C; Voyer H; Kessous-Elbaz A; Berrada F; Begin P; Giroux L; Viscidi R; Department of Microbiology and Infectious Diseases, Hopital; Notre-Dame, Montreal, Quebec, Canada.


Abstract: A convenient assay combining solution hybridization and enzyme immunoassay for DNA-RNA hybrids (polymerase chain reaction-enzyme immunoassay [PCR-EIA]) was developed to detect human immunodeficiency virus type 1 (HIV-1) provirus amplified by the PCR and was compared with oligomer hybridization with 32P-labeled SK19. In PCR-EIA, a fragment of the HIV-1 gag gene from peripheral blood mononuclear cells was first amplified with primer pair SK38/SK39 or O1/O2. PCR-amplified material was reacted in solution with a biotinylated RNA probe. Biotinylated hybrids were measured in a microtiter-plate EIA with antibiotin antibody and a beta-D-galactosidase-conjugated monoclonal antibody to DNA-RNA hybrids. Ten copies of HIV-1 DNA could be detected by PCR-EIA by using two different sets of primers. HIV-1 DNA was detected in 104 of 108 peripheral blood mononuclear cell samples by using SK38/39 and oligomer hybridization, in 104 of 108 samples by using SK38/SK39 and PCR-EIA, and in 104 of 108 samples by using O1/O2 and PCR-EIA. HIV-1 provirus was detected in 107 of 108 samples by using a combination of two sets of primers. One sample from a seropositive patient was negative in all three PCR assays, and six samples gave discordant results between primer pairs. Six of the latter samples scored negative in a PCR for beta-globin but became positive when the sample was diluted before amplification. When applied to clinical samples, PCR-EIA generated results similar to those of an isotopic assay for detection of amplified DNA.
Keywords: Base Sequence Biotin Comparative Study DNA, Viral/GENETICS/*ISOLATION & PURIF Evaluation Studies Human HIV Infections/*DIAGNOSIS/GENETICS *HIV-1/GENETICS Immunoenzyme Techniques Male Molecular Sequence Data Nucleic Acid Hybridization Polymerase Chain Reaction/*METHODS Proviruses/GENETICS/ISOLATION & PURIF RNA Probes Support, Non-U.S. Gov't JOURNAL ARTICLE

KWDbasesequencebiotincomparativestudydna,viral/genetics/KWDisolation&purifevaluationstudieshumanhivinfections/KWDdiagnosis/geneticsKWDhiv-1/geneticsimmunoenzymetechniquesmalemolecularsequencedatanucleicacidhybridizationpolymerasechainreaction/KWDmethodsproviruses/genetics/isolation&purifrnaprobessupport,non-uKWDsKWDgov'tjournalarticle
920530
M9250910


Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .